HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The efficacy of semiselective intraarterial infusion therapy in advanced or recurrent gastric cancer].

Abstract
We use CDDP and have compared the semiselective intraarterial infusion (ia group) with intravenous infusion (i.v. group) by measuring levels of the administered drug in blood and the abdominal organ tissues. In portal blood, the ia group showed a significant increase compared with the i.v. group. The patient tissue level was compared between the two groups. Higher levels were obtained in the peritoneum in the ia group. These results suggest that semiselective intraarterial infusion therapy is effective in peritoneal dissemination.
AuthorsK Okada, T Suda, F Kito, T Imada, Y Yamamoto, H Takemura, T Okukawa, Y Rino, O Kobayashi, M Sairenji
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 20 Issue 11 Pg. 1661-4 (Aug 1993) ISSN: 0385-0684 [Print] Japan
PMID8373242 (Publication Type: Journal Article)
Chemical References
  • Cisplatin
Topics
  • Cisplatin (administration & dosage, blood, pharmacokinetics)
  • Gastric Mucosa (metabolism)
  • Humans
  • Infusions, Intra-Arterial
  • Infusions, Intravenous
  • Liver Neoplasms (drug therapy, secondary)
  • Lymph Nodes (metabolism)
  • Stomach Neoplasms (drug therapy, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: